Skip to main content

Market Overview

Feuerstein Not Excited About JPMorgan Biotech Conference

Share:
Feuerstein Not Excited About JPMorgan Biotech Conference

JPMorgan's Annual Healthcare Conference is one of the largest gathering of healthcare companies, executives, investors, and other stakeholders and kicks off on Monday.

Chris Lewis of Roth Capital Partners commented in a note on January 5 that he is expecting "a number of preannouncments" within the space. The analyst added that many companies are expected to issue preliminary fourth quarter 2015 results and/or 2016 guidance Monday morning.

Meanwhile, The Street's Adam Feuerstein, a notable biotech expert, thinks the sector's outlook is dire. On January 7, Feuerstein tweeted that 2016 will be a "bummer year" for biotech stocks.

Here are some of Feuerstein's other notable Tweets expressing his bearish outlook for the sector.

 

Related Articles

View Comments and Join the Discussion!

Posted-In: Adam Feurestein Chris Lewis JPMorgan Biotech ConferenceAnalyst Color News Short Ideas Previews Trading Ideas Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com